Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Desjardins selling hard

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Jun 27, 2018 11:53am

59 Views

Post# 28237107

RE:RE:RE:RE:RE:RE:RE:Desjardins selling hard

So I was one that posted to the news release. I had misread what you were looking for. I thought you were after some proof about the press release regarding the trial. So I'll own that.

But lets take a look at your actions unclepieman. What kind of person sits there and hurls insults at people because they're not there in person to punch you in the face? A small minded coward. There's absolutely no need for that anywhere and you only debase yourself.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide